EnteroBiotix has completed enrolment of patients in a Phase 2 double-blind, placebo-controlled, multi-centre clinical study in irritable bowel syndrome (IBS) and is progressing a Phase 2a study with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback